Maritech® fucoidan attains GRAS status
Marinova’s fucoidan extracts from the seaweed species Undaria pinnatifida and Fucus vesiculosus have attained GRAS (Generally Recognized As Safe) status with the US Food and Drug Administration (FDA). These Maritech® ingredients are the first and only high purity fucoidan extracts to achieve FDA notified GRAS status.
The FDA issued a “no questions” response to findings by an independent panel of qualified experts who determined that these Maritech® fucoidan extracts are safe for ingestion as a food ingredient. Comprehensive safety data and scientific research findings were assessed in the evaluation process, confirming safety at rates of up to 250mg per day.
Marinova’s Operations Manager, Dr Damien Stringer, commented on the achievement. “GRAS recognition is testament to the safety and quality of Maritech® fucoidan extracts, giving our customers even greater confidence that they are getting the highest quality and most effective fucoidan ingredients on the market.”
The attainment of GRAS status complements existing regulatory accreditations in other jurisdictions, including Australia, Canada, Europe and China, and adds to the certified-organic, non-GMO, Kosher and Halal certifications of the Maritech® fucoidan extract range.
News of Marinova’s GRAS status has received widespread media interest with feature articles published in NutritionInsight, Nutraceutical Business Review and NutraIngredients.